Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
May 7 FBIO Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
May 7 EQ Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
May 7 FGEN FibroGen to Participate in Upcoming Investor Conferences
May 7 FGEN FibroGen Inc (FGEN) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
May 7 FGEN FibroGen, Inc. (FGEN) Q1 2024 Earnings Call Transcript
May 6 CLDX Celldex GAAP EPS of -$0.56, revenue of $0.16M
May 6 FGEN FibroGen GAAP EPS of -$0.33 beats by $0.20, revenue of $55.9M beats by $19.45M
May 6 FGEN FibroGen Reports First Quarter 2024 Financial Results
May 6 CLDX Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 6 BLRX BioLineRx Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024
May 5 DCPH Wall Street Breakfast: The Week Ahead
May 3 FGEN FibroGen Q1 2024 Earnings Preview
May 3 DCPH The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
May 2 FBIO Mustang Bio Announces Closing of $4 Million Public Offering
May 2 DCPH Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
May 2 EQ We're Keeping An Eye On Equillium's (NASDAQ:EQ) Cash Burn Rate
May 1 FBIO Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
May 1 CYTK Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags